Anomalous Intravascular Casts (AICs) and Emerging Pathological Research

Analysis of Anomalous Intravascular Casts (AICs) and Emerging Pathological ResearchExecutive SummarySince 2021, a novel pathological phenomenon involving "rubbery white blood clots"—formally termed Anomalous Intravascular Casts (AICs)—has been identified by embalmers and clinicians globally. Recent research, spearheaded by New Zealand doctors and international laboratories, has produced a three-part comprehensive characterization of these structures.Key findings indicate that AICs are not typical post-mortem clots; they are elastic, lumen-conforming structures that show evidence of forming while blood is still flowing (ante-mortem). Chemically, they present a "bizarre" fingerprint, being depleted of sulfur and enriched with phosphorus, suggesting a hybrid organic-inorganic matrix. Proteomic analysis reveals a significant lack of plasminogen—the enzyme required for clot breakdown—and highly abnormal fibrin chain ratios. There is a noted temporal correlation between the emergence of these clots and the rollout of COVID-19 injections, leading researchers to call for urgent investigation into the role of spike proteins and genetic vaccine platforms. Despite these findings, the mainstream medical community and major pathological journals have remained largely silent on the phenomenon.